NASDAQ$SIGA

SIGA Technologies, Inc · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

SIGA Technologies' financial results for Q2 2021 reflected a decrease in total revenues and net income compared to Q2 2020, but international revenues from oral TPOXX® showed a steady positive result.

SIGA Technologies reported Q2 2021 financial results with a decrease in total revenues to $8.7 million compared to $40.3 million in Q2 2020. Net income decreased to $0.2 million from $20.9 million in the same period last year. However, the company saw $7 million in international revenues from oral TPOXX® deliveries to Canada.

  • Total revenues for the second quarter of 2021 were $8.7 million, compared to $40.3 million for the second quarter of 2020.
  • Net income for the second quarter of 2021 was $0.2 million, compared to $20.9 million for the second quarter of 2020.
  • The company delivered approximately $7 million of oral TPOXX® to PHAC under the contract awarded in January 2021.
  • SIGA filed a new drug application with the FDA for the intravenous formulation of TPOXX.

Headline financials

Total Revenue

$8.65M

Previous: $40.3M-78.6%
EPS (adj)

$0.00

Previous: $0.26-99.2%
Capital Expenditures

-$24.4K

Previous: -$15.5K-57.6%
Free Cash Flow

$145K

Previous: $20.9M-99.3%
Net Income

$169K

Previous: $20.9M-99.2%
Operating Income

$1.1K

Previous: $28.8M-100.0%
Gross Profit

$7.66M

Previous: $35.6M-78.5%
Cash & Equivalents

$98.5M

Previous: $53.1M+85.6%
Total Assets

$134M

Previous: $120M+11.0%

Revenue & EPS history

SIGA Technologies · Revenue · Quarterly

$8.65M

Q2 2021-78.6%vs Q2 2020
Beat estimate in 0 of 2 quarters(0%)
ActualEstimate

Revenue by segment

SIGA Technologies · $8.65M total across 2 segments · Q2 2021

  • Product Sales
    $6.92M-82.1%
  • R&D Revenues
    $1.73M+0.3%

Forward guidance

The company is working with Meridian in a new foreign jurisdiction toward finalizing an order that would be similar in size to the initial orders received from Canada in 2020 and early 2021. The timing of the completion of the order has been, and may continue to be impacted by the COVID-19 pandemic.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

-0.2%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+2.4%

Avg return

30 days after

41%

26 / 64 earnings

Positive

+31.9%

Q4 2023

Best reaction

-27.8%

Q1 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.4%-5.5%-8.5%
Q4 2025-3.0%-3.4%-22.8%
Q3 2025-20.2%-24.0%-24.1%
Q1 2025+4.4%+9.0%+10.8%
Q4 2024+7.0%+0.5%+6.4%
Q3 2024-1.9%-8.5%-9.8%
Q2 2024-12.8%-14.3%-9.5%
Q1 2024-27.8%-28.2%-26.7%
Q4 2023+31.9%+49.9%+88.3%
Q3 2023-4.4%-2.2%+16.9%
Q2 2023-3.7%-10.0%-21.9%
Q1 2023+5.1%+1.8%-0.7%
Q4 2022-3.8%-7.8%-13.4%
Q3 2022+7.5%+9.8%+1.1%
Q2 2022+27.4%+24.6%-21.0%
Q1 2022+3.6%+4.0%+60.7%
Q4 2021+3.0%+6.6%+22.4%
Q3 2021-0.7%+0.0%+2.8%
Q2 2021-2.9%-4.0%+9.1%
Q1 2021-0.7%-8.4%-10.4%
Q4 2020+1.7%+9.3%+1.2%
Q3 2020+2.0%+3.4%-0.9%
Q2 2020+14.3%+5.5%-1.9%
Q1 2020-1.4%+1.4%+2.9%
Q4 2019+10.4%+0.4%+0.2%
Q3 2019-3.2%-1.8%-19.8%
Q2 2019+0.2%-1.7%+2.7%
Q1 2019+1.5%-1.3%-12.8%
Q4 2018-4.4%-1.6%-6.3%
Q3 2018+8.4%+5.7%+29.1%
Q2 2018+0.3%+7.7%+1.4%
Q1 2018-0.5%+2.4%-3.9%
Q4 2017-0.6%-7.0%-2.3%
Q3 2017+2.8%-1.1%+3.9%
Q2 2017-1.6%-1.6%-1.9%
Q1 2017-0.3%+0.6%-8.0%
Q4 2016-0.6%+0.0%-4.1%
Q3 2016-5.7%+3.8%+54.8%
Q2 2016+4.5%+4.1%+11.4%
Q1 2016+1.1%
Q4 2015+1.1%
Q3 2015+2.4%
Q2 2015-0.9%
Q1 2015+5.7%
Q4 2014-1.3%
Q3 2014-0.7%
Q2 2014-4.9%
Q1 2014-1.4%
Q4 2013-2.7%
Q3 2013-3.5%
Q2 2013-2.8%
Q1 2011-2.4%
Q4 2012-2.5%
Q3 2012+6.5%
Q2 2012+5.3%
Q1 2012+4.5%
Q4 2011-1.4%
Q4 2009-1.4%
Q3 2010-6.1%
Q3 2011-6.1%
Q2 2011-12.0%
Q2 2010-12.0%
Q4 2010-12.0%
Q1 2010-1.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro